dc.contributor.author | Liebmann, Edward P. | |
dc.contributor.author | Scheuermann, Taneisha S. | |
dc.contributor.author | Faseru, Babalola | |
dc.contributor.author | Richter, Kimber P. | |
dc.date.accessioned | 2020-11-23T15:24:25Z | |
dc.date.available | 2020-11-23T15:24:25Z | |
dc.date.issued | 2019-04-24 | |
dc.identifier.citation | Liebmann, E. P., Scheuermann, T. S., Faseru, B., & Richter, K. P. (2019). Critical steps in the path to using cessation pharmacotherapy following hospital-initiated tobacco treatment. BMC health services research, 19(1), 246. https://doi.org/10.1186/s12913-019-4059-4 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/30899 | |
dc.description | This work is licensed under a Creative Commons Attribution 4.0 International License. | en_US |
dc.description.abstract | Background
Hospital-initiated smoking cessation interventions utilizing pharmacotherapy increase post-discharge quit rates. Use of smoking cessation medications following discharge may further increase quit rates. This study aims to identify individual, smoking-related and hospitalization-related predictors of engagement in three different steps in the smoking cessation pharmacotherapy utilization process: 1) receiving medications as inpatient, 2) being discharged with a prescription and 3) using medications at 1-month post-hospitalization, while accounting for associations between these steps.Methods
Study data come from a clinical trial (N = 1054) of hospitalized smokers interested in quitting who were randomized to recieve referral to a quitline via either warm handoff or fax. Variables were from the electronic health record, the state tobacco quitline, and participant self-report. Relationships among the predictors and the steps in cessation medication utilization were assessed using bivariate analyses and multivariable path analysis.Results
Twenty-eight percent of patients reported using medication at 1-month post-discharge. Receipt of smoking cessation medications while hospitalized (OR = 2.09, 95%CI [1.39, 3.15], p < .001) and discharge with a script (OR = 4.88, 95%CI [3.34, 7.13], p < .001) were independently associated with medication use at 1-month post-hospitalization. The path analysis also revealed that the likelihood of being discharged with a script was strongly influenced by receipt of medication as an inpatient (OR = 6.61, 95%CI [4.66, 9.38], p < .001). A number of other treatment- and individual-level factors were associated with medication use in the hospital, receipt of a script, and use post-discharge.Conclusions
To encourage post-discharge smoking cessation medication use, concerted effort should be made to engage smokers in tobacco treatment while in hospital. The individual and hospital-level factors associated with each step in the medication utilization process provide good potential targets for future implementation research to optimize treatment delivery and outcomes. | en_US |
dc.description.sponsorship | National Heart, Lung, and Blood Institute (U01 HL105232) | en_US |
dc.publisher | BMC | en_US |
dc.rights | © The Author(s). 2019 | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
dc.subject | Smoking cessation | en_US |
dc.subject | Medication reconciliation | en_US |
dc.subject | Tobacco use cessation devices | en_US |
dc.subject | Patient discharge | en_US |
dc.title | Critical steps in the path to using cessation pharmacotherapy following hospital-initiated tobacco treatment | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Liebmann, Edward P. | |
kusw.kudepartment | Psychology | en_US |
dc.identifier.doi | 10.1186/s12913-019-4059-4 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-0351-4336 | en_US |
kusw.oaversion | Scholarly/refereed, publisher version | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC6480776 | en_US |
dc.rights.accessrights | openAccess | en_US |